Breast cancer has become the worlds largest cancer

seriously endangering womens health

which also indicates the importance of early diagnosis and treatment. Integrated positron emission tomography (PET)/magnetic resonance imaging (MRI)

as a new multi-modal imaging tool with great potential

has gradually entered clinical practice. It can not only provide metabolic information based on PET

but also obtain high-resolution morphological data based on MRI and perform multi-sequence functional imaging. It can more accurately judge lymph node

bone

liver metastasis and evaluate the efficacy of neoadjuvant chemotherapy under the condition of low radiation dose

and is expected to show its unique advantages in the field of breast cancer. This article reviewed the application of integrated PET/MRI in the diagnosis and treatment of breast cancer

and evaluated its strengths and weaknesses.